HTA dossiers are not all the same. It is not enough to have technical-scientific rigor without the meticulous strategic alignment of product value generation with the company’s Access, Medical Affairs and Marketing areas. Our team is composed of technicians with doctoral level in topics related to Health Technology Assessment and senior consultants with extensive experience in the healthcare ecosystem and the pharmaceutical industry. It is for this reason that we have the highest approval rates for federal agencies in SUS (CONITEC) and in Supplementary Health (ANS, within the scope of the Rol update).

The entire technical-scientific framework follows the vanguard of knowledge produced in the world of health technology assessment, evidence-based health, health economics and health economic evaluation. Furthermore, every report prepared by the MAPESolutions team goes through a process of translating cold and complex scientific information into a more accessible language, easier to interpret and highly capable of being implemented in the routine of health managers, payers and regulatory agencies.